Equine therapeutics research Australia: A consortium determining reliable excretion times for equine medications

Bryden, W. L., Cawdell-Smith, A. J., Jarrett, M. W., Kirkpatrick, C. M., McKinney, A. R., Nobel, G. K., Russo, C., Schneiders, F. I., Sillence, M. N., Vine, J. H. and Young, E. B. (2008). Equine therapeutics research Australia: A consortium determining reliable excretion times for equine medications. In: Proceedings of the Australian Equine Science Symposium. Research for the 21st Century Horse Industry: From Genomics to the Winning Post., Gold Coast, Australia, (14-14). 4-6 June, 2008.


Author Bryden, W. L.
Cawdell-Smith, A. J.
Jarrett, M. W.
Kirkpatrick, C. M.
McKinney, A. R.
Nobel, G. K.
Russo, C.
Schneiders, F. I.
Sillence, M. N.
Vine, J. H.
Young, E. B.
Title of paper Equine therapeutics research Australia: A consortium determining reliable excretion times for equine medications
Conference name Research for the 21st Century Horse Industry: From Genomics to the Winning Post.
Conference location Gold Coast, Australia
Conference dates 4-6 June, 2008
Proceedings title Proceedings of the Australian Equine Science Symposium
Place of Publication Australia
Publisher Australian Equine Genetics Research Centre
Publication Year 2008
Volume 2
Start page 14
End page 14
Total pages 1
Language eng
Abstract/Summary Equine Therapeutics Research Australia (ETRA) is a consortium of three Universities and the four Australian Racing Laboratories, with funding from the Rural Industries Research and Development Corporation (RIRDC). The primary role of ETRA is to determine the pharmacokinetics of equine therapeutic drugs using groups of 12 horses of racing age. Australian rules of racing and other equestrian events forbid horses from competing if their blood or urine contains detectable concentrations of any therapeutic substance on the day of competition. Therefore drug withholding times need to be judged carefully. Uncertainty about withholding times stems from the fact that available data published by Equine Veterinarians Australia in the ‘White Book’, has been obtained mostly from a series of ad hoc drug administration trials involving only one or two horses. The likely variation between horses can only be guessed from such limited data and detection times cannot be extrapolated to the entire horse population with confidence. Unfortunately, this uncertainty about excretion and detection times for many important equine medications can adversely effect horse welfare, the reputation of the owner or trainer and the integrity of the sport. ETRA was formed to address this uncertainty and 18 medications will be evaluated over the next three years. The medications are chosen following consultation with a reference group of peak industry bodies: Equine Veterinarians Australia, The Australian Horse Industry Council, The Australian Racing Board, The Equestrian Federation of Australia, Harness Racing Australia, Queensland Racing, Racing and Wagering Western Australia, Racing New South Wales and Racing Victoria. Medications tested by the research group in the lead up to this project were frusemide and triamcinolone acetonide. Hydrocortisone, dexamethasone, flunixin and lignocaine are currently being tested and it is planned to test methyl prednisolone, clenbuterol, acepromazine, procaine penicillin and prilocaine over the next year. The complete list of substances to be tested is still to be finalised.
Subjects 0707 Veterinary Sciences
Keyword Animal science
Horses
Racing
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: School of Agriculture and Food Sciences
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Fri, 16 Apr 2010, 11:15:33 EST by Ms May Balasaize on behalf of Faculty Of Nat Resources, Agric & Veterinary Sc